N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide

C41H56N4O9S — CID 67496225

IUPACN-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](CNC(=O)N4CCOCC4)[C@@H]3c3ccc(COCCOC)cc3)cc21
InChIInChI=1S/C41H56N4O9S/c1-31-5-12-36(13-6-31)55(47,48)45-27-35(26-42-41(46)44-16-20-51-21-17-44)40(34-10-7-32(8-11-34)29-52-24-23-50-3)39(28-45)54-30-33-9-14-38-37(25-33)43(18-22-53-38)15-4-19-49-2/h5-14,25,35,39-40H,4,15-24,26-30H2,1-3H3,(H,42,46)/t35-,39+,40+/m1/s1
InChIKeyCLDVKTNNNQRBET-LOFIATCASA-N
MW780.98 g/mol
LogP4.42
Rot. Bonds17

About N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide

N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide (PubChem CID 67496225) has the molecular formula C41H56N4O9S and a molecular weight of 780.98 g/mol. Its IUPAC name is N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide.

Molecular Properties

Compound NameN-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide
PubChem CID67496225
Molecular FormulaC41H56N4O9S
Molecular Weight780.98 g/mol
Exact Mass780.38
IUPAC NameN-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](CNC(=O)N4CCOCC4)[C@@H]3c3ccc(COCCOC)cc3)cc21
InChIInChI=1S/C41H56N4O9S/c1-31-5-12-36(13-6-31)55(47,48)45-27-35(26-42-41(46)44-16-20-51-21-17-44)40(34-10-7-32(8-11-34)29-52-24-23-50-3)39(28-45)54-30-33-9-14-38-37(25-33)43(18-22-53-38)15-4-19-49-2/h5-14,25,35,39-40H,4,15-24,26-30H2,1-3H3,(H,42,46)/t35-,39+,40+/m1/s1
InChIKeyCLDVKTNNNQRBET-LOFIATCASA-N
XLogP4.42
TPSA128.34 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds17
Heavy Atoms55
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500780.98
LogP ≤ 54.42
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide?
The IUPAC name of N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide (CID 67496225) is N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide.
What is the SMILES notation for N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide?
The canonical SMILES for N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide is COCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)C[C@@H](CNC(=O)N4CCOCC4)[C@@H]3c3ccc(COCCOC)cc3)cc21.
What is the InChIKey of N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide?
The InChIKey is CLDVKTNNNQRBET-LOFIATCASA-N. The full InChI is InChI=1S/C41H56N4O9S/c1-31-5-12-36(13-6-31)55(47,48)45-27-35(26-42-41(46)44-16-20-51-21-17-44)40(34-10-7-32(8-11-34)29-52-24-23-50-3)39(28-45)54-30-33-9-14-38-37(25-33)43(18-22-53-38)15-4-19-49-2/h5-14,25,35,39-40H,4,15-24,26-30H2,1-3H3,(H,42,46)/t35-,39+,40+/m1/s1.
What are the key properties of N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide?
N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide has a molecular weight of 780.98 g/mol, XLogP of 4.42, 17 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(3R,4R,5R)-4-[4-(2-methoxyethoxymethyl)phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-3-yl]methyl]morpholine-4-carboxamide is sourced from PubChem (CID 67496225), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).